CRIS Current Research Information System

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 54
Titolo Autore(i) Anno Periodico Editore Tipo File
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS Pagnotta E.; Calonghi N.; Parolin C.; Mangano C.; Boga C.; Naldi M.; Santucci M.A.; Masotti L. 2006-01-01 ITALIAN JOURNAL OF BIOCHEMISTRY - 4.02 Riassunto (Abstract) -
A new class of dual SRC/ABL kinase inhibitors for the treatment of imatinib-resistant chronic myeloid leukemias Corradi V.; Mancini M.; Corrado P.; Barbieri E.; Santucci M.A.; Schenone S.; Botta M. 2007-01-01 - s.n 4.02 Riassunto (Abstract) -
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein Mancini M.; Zuffa E.; Corrado P.; Pagnotta E.; Brusa G.; Corradi V.; martinelli G.; Barbieri E.; ...Santucci M.A. 2007-01-01 - s.n 4.02 Riassunto (Abstract) -
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies Corrado P.; Brusa G.; Mancini M.; Zuffa E.; Corradi V.; Martinelli G.; Barbieri E.; Santucci M.A. 2007-01-01 - s.n 4.02 Riassunto (Abstract) -
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma Brusa G.; Zuffa E.; Remondini D.; Castellani G.; Serra M.; Hattinger C.M.; Morandi L.; Zinzani P....L.; Mancini M.; Corrado P.; Barbieri E.; Santucci M.A. 2007-01-01 - s.n 4.02 Riassunto (Abstract) -
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells Calonghi N; Pagnotta E; Parolin C; Molinari C; Boga C; Dal Piaz F; Brusa GL; Santucci MA; Masotti L. 2007-01-01 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS - 1.01 Articolo in rivista -
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 Mancini M; Brusa G; Zuffa E; Corrado P; Martinelli G; Grafone T; Barbieri E; Santucci MA 2007-01-01 LEUKEMIA RESEARCH - 1.01 Articolo in rivista -
P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2 Zuffa E.; Mancini M.; Brusa G.; Pagnotta E.; Hattinger C.M.; Serra M.; Remondini D.; Castellani G....; Corrado P.; Barbieri E.; Santucci M.A. 2008-01-01 INTERNATIONAL JOURNAL OF RADIATION BIOLOGY - 1.01 Articolo in rivista -
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Radi M; Crespan E; Botta G; Falchi F; Maga G; Manetti F; Corradi V; Mancini M; Santucci MA; Schen...one S; Botta M. 2008-01-01 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS - 1.01 Articolo in rivista -
IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia Mancini M; Zuffa E; Veljkovic N; Brusa G; Corrado P; Corradi V; Martinelli G; Barbieri E; Santucc...i MA. 2008-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -
Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia Corrado P; Mancini M; Brusa G; Petta S; Martinelli G; Barbieri E; Santucci MA 2009-01-01 LEUKEMIA - 1.01 Articolo in rivista -
C6-Unsubstituted Pyrazolo[3,4-d]pyrimidines Are Dual Src/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines. Santucci MA; Corradi V; Mancini M; Manetti F; Radi M; Schenone S; Botta M. 2009-01-01 CHEMMEDCHEM - 1.01 Articolo in rivista -
14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia Mancini M; Veljkovic N; Corradi V; Zuffa E; Corrado P; Pagnotta E; Martinelli G; Barbieri E; Sant...ucci MA. 2009-01-01 TRAFFIC - 1.01 Articolo in rivista -
RAD001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia M. Mancini; S. Petta; G. Martinelli; E. Barbieri; M.A. Santucci 2010-01-01 JOURNAL OF CELLULAR BIOCHEMISTRY - 1.01 Articolo in rivista -
Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. Mancini M.; Petta S.; Iacobucci I.; Salvestrini V. ; Barbieri E.; Santucci M. A. 2010-01-01 CELLULAR SIGNALLING - 1.01 Articolo in rivista -
New SRC/ABL inhibitors for chronic myeloid leukemia therapy show selectivity for T315I ABL mutant CD34(+) cells Santucci MA; Mancini M; Corradi V; Iacobucci I; Martinelli G; Botta M; Schenone S 2010-01-01 INVESTIGATIONAL NEW DRUGS - 1.01 Articolo in rivista -
Idetification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis. Corradi V.; Mancini M.; Manetti F.; Petta S.; Santucci M.A.; Botta M. 2010-01-01 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS - 1.01 Articolo in rivista -
mTOR inhibitor RAD001 (Everloimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-Abl protein M. Mancini; V. Corradi; S. Petta; G. Martinelli; E. Barbieri; M.A. Santucci 2010-01-01 LEUKEMIA RESEARCH - 1.01 Articolo in rivista -
HIF 1 Alpha: A Suitable Target for Multiple Myeloma PERRONE G; BORSI E; TERRAGNA C; DURANTE S; MARTELLO M; ALUIGI M; MANCINI M; ZAMAGNI E; TACCHETTI ...P; BRIOLI A; PANTANI L; ZANNETTI BA; MARTINELLI G; SANTUCCI MA; BACCARANI M; CAVO M 2011-01-01 BLOOD - 4.02 Riassunto (Abstract) -
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA G Perrone; E Borsi; C Terragna; M Martello; M Mancini; M Aluigi; MA Santucci; G Martinelli; M Bac...carani; M Cavo 2012-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
Mostrati risultati da 21 a 40 di 54
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile